Category: Health & Medicines > Medicines
Country/Region: China State/Province: Shandong
Main Products: D-cysteine Hydrochloride Monohydrate, N-[4-Ethyl-2, 3-dioxo-1-piperazinylcar-bonyl]-amino-p-hydroxyphenylacetic Acid, Star DBD-02, Star DBD-03, L-cysteine Hydrochloride Monohydrate, GCLE, Trisodium 4-carboxy-5-mercapto-3-hydroxy-isothiazole
Business Type: Wholesaler, Services
Year Established: 2005
Employees: 11 - 50 People
Plant Area: 5,000-10,000 square meters
Fax: 86-530-3719899
Main Markets: South America 8% Africa 12% Eastern Asia 8% Domestic Market 11% North America 10% Eastern Europe 10% Southern Europe 9% Mid East 10% Northern Europe 10% Oceania 12%
Trade Capacity: FOB, FAS, DAF
Contract Manufacturing: OEM Service Offered
Nearest Port: Heze
Annual Revenue: confidential
Total Revenue: US$50 Million - US$100 Million
Export Revenue: Below US$1 Million
Annual Output: US$2.5 Million - US$5 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 41% - 50%
Payment Modes: USD, JPY, GBP
Lead Time: 10 days
Import/Export Mode: LLC (Limited Liability Corp)